Here's how Telstra Corporation Ltd could benefit from television's demise

Despite Foxtel facing challenges, overall demand for Telstra Corporation Ltd (ASX:TLS) services looks bright.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

According to research by ZenithOptimedia, advertising spend on the internet is set to overtake spending on television advertisements by 2017.

Driving the structural shift towards the internet are increased advertising spends on social media, online video and paid search platforms.

Arguably it's not an unexpected prediction, however, it may still be a wake-up call for some investors.

As investors in commodity businesses have experienced (painfully) over the past few years, just a small shift in supply and demand can have a dramatic effect on price.

A similar fate could be awaiting television network owners…

Recent news reports have speculated that Telstra Corporation Ltd (ASX: TLS) – which owns 50% of pay television business Foxtel – is considering offloading the Foxtel asset due to its poor outlook. That outlook is based on fierce competition from online streaming providers such as Netflix.

With all three of Australia's major free-to-air (FTA) networks listed on the ASX, shareholders of Seven West Media Ltd (ASX: SWM), Nine Entertainment Co Holdings Ltd (ASX: NEC) and Ten Network Holdings Limited (ASX: TEN) could all be facing structural challenges even greater than what the market is currently factoring in!

More upside than downside

Despite the worrying outlook for FTA networks and Foxtel, arguably the outlook for Telstra remains bright.

Even if Foxtel is divested or experiences significant earnings declines, ultimately Telstra's market-leading exposure to higher future demand for internet services and online data outweighs the possible lost earnings from Foxtel.

Motley Fool contributor Tim McArthur has no position in any stocks mentioned. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »